DIA 48th Annual Meeting
Click here to go to the previous page
Recent Advances in Adaptive Clinical Trial Designs for Medical Writers
Track
:
Track 06: Medical Writing and Medical Communications
Program Code:
380
Date:
Wednesday, June 27, 2012
Time:
3:30 PM to 5:00 PM
EST
CHAIR
:
John Whitaker, INC Research
PRESENTER
(S):
John Whitaker, INC Research
Annie Solterbeck, Statistical Revelations, Australia H.M. James Hung, FDA, United States
Description
In this session, speakers will review the types of adaptations that can be built into clinical trials and the types of concerns these adaptations raise with regulators and the scientific community. Statistical methodologies will also be reviewed.
Learning Objectives:
Describe the current uses and future directions of adaptive trials in drug development
Discuss prior successes and failures in the use of adaptive trial designs
Identify the complex position of regulatory agencies on the use of adaptive trials.
Learning Objectives:
Describe the current uses and future directions of adaptive trials in drug development
Discuss prior successes and failures in the use of adaptive trial designs
Identify the complex position of regulatory agencies on the use of adaptive trials.
This session is a part of:
Handout Online
